Nina Blazeska

  The data in the IEDB is primarily derived from scientific publications. These are designated as having the "Reference Type" of "Literature". This type of record has a PubMed identifier and an IED...

PHOTO: 2021 IEDB Virtual User Workshop - Day 1 (28 October 2021) - Presenters on Zoom Webinar Our team holds an annual user workshop in October/November to which we invite both those new to the IE...

The attached document is the agreed upon Statement of Work that the IEDB (contract number 75N93019C00001) has with the National Institute of Allergy and Infectious Diseases (NIAID). It outlines the...

The attachment on this page houses two key plans that were agreed upon with the National Institute of Allergy and Infectious Diseases (NIAID) at the outset of the Immune Epitope Database (IEDB) con...

IEDB Annual Compendium for 2020 This Compendium of the Immune Epitope Database and Analysis Resource, and consists of three sections. The first section contains a list of the antibody and T cell ep...

In 2020, the IEDB Expert Committee was established. It is a volunteer-based group of scientists with diverse backgrounds; from B and T cell expertise to immunotherapy and bioinformatic tools experi...

The following categories are assigned during data curation based on what the authors indicate in the paper: Positive High Positive Intermediate Positive Low If there is no binding or outcome in t...

Overview: As of 2021, the IEDB has updated the results page to include new specialized Filter Options, which provide a set of new, or previously hidden, filter parameters for specific search purpos...

PHOTO: 2020 IEDB Virtual User Workshop - Day 1 (5 November 2020) - Presenters on Zoom Webinar Our team holds an annual user workshop in October/November to which we invite both those new to the IE...

IEDB Annual Compendium for 2019 This Compendium of the Immune Epitope Database and Analysis Resource, and consists of three sections. The first section contains a list of the antibody and T cell ep...